Subject: FW: REMDESIVIR SOLIDARITY TRIALS NEGATIVE REPORTS
From: Vinay Dixit <[email-masked]>
To: Maia Nikoleishvili <[email-masked]>
Date: Wed, 21 Oct 2020 09:08:47 +0000

Dear Maia Madam,

Please find latest information on Remdesivir.

In continuation to supporting Remdesivir use in COVID please find below additional info, if there is any query raised against Remdesivir:

Gilead:
Additionally, we are pleased that today WHO has prequalified remdesivir, which assures procurement agencies such as the United Nations that Veklury has met global standards of quality,
safety and efficacy.

Gilead Remdesivr  is the First remdesivir WHO prequalified - 15 OCTOBER 2020.

https://extranet.who.int/prequal/news/first-remdesivir-prequalified

https://www.gilead.com/news-and-press/company-statements/gilead-sciences-statement-on-the-solidarity-trial

Best regards,

Dr. Shyam Akku

Confidentiality Notice:

This e-mail transmission may contain confidential or legally privileged information that is intended only for the individual or entity named in the e-mail
address. If you are not the intended recipient, you are hereby notified that any disclosure, copying, distribution, or reliance upon the contents of this e-mail is strictly prohibited. If you have received this e-mail transmission in error, please delete the
message
and any attachments
from your Inbox.